Morgan Jones, MD, will use the award to inform the design of a pilot trial centered on breast cancer. Her specific interests are in triple-negative breast cancer, disparities in treatment outcomes, and tumor microenvironments.
LEXINGTON, Ky. (Aug. 7, 2024) – Despite the prevalence and toll of late-onset Alzheimer’s disease—the most common type, which begins after age 65— causes of the disease remain only partly understood. Is it genes? Lifestyle? Environment?